|
AZI2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.97772917434713E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.07309733216243E-12 |
| Normal-vs-Stage2 |
1.91559999999091E-05 |
| Normal-vs-Stage3 |
1.642190E-04 |
| Normal-vs-Stage4 |
1.163560E-02 |
| Stage1-vs-Stage2 |
8.461800E-01 |
| Stage1-vs-Stage3 |
8.364600E-01 |
| Stage1-vs-Stage4 |
6.595000E-01 |
| Stage2-vs-Stage3 |
7.765600E-01 |
| Stage2-vs-Stage4 |
5.972400E-01 |
| Stage3-vs-Stage4 |
8.177400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.05437880648651E-12 |
| Normal-vs-AfricanAmerican |
8.14169998086811E-09 |
| Normal-vs-Asian |
7.069900E-02 |
| Caucasian-vs-AfricanAmerican |
9.498600E-01 |
| Caucasian-vs-Asian |
9.823600E-01 |
| AfricanAmerican-vs-Asian |
9.669800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63347113613099E-12 |
| Normal-vs-Female |
6.968300E-04 |
| Male-vs-Female |
1.180500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.65310000027819E-08 |
| Normal-vs-Extreme_Weight |
2.96984659087229E-13 |
| Normal-vs-Obese |
2.32200000338523E-08 |
| Normal-vs-Extreme_Obese |
4.356600E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.893600E-01 |
| Normal_Weight-vs-Obese |
5.368000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.081800E-01 |
| Extreme_Weight-vs-Obese |
1.341770E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.918200E-01 |
| Obese-vs-Extreme_Obese |
4.557600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.951500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.66309965798916E-10 |
| Normal-vs-Age(61-80Yrs) |
6.83897383169096E-14 |
| Normal-vs-Age(81-100Yrs) |
8.15189999947563E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.041450E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.034100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.055900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.070000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.781800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.156400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.69029243327168E-12 |
| Normal-VS-Type2 PRCC |
2.43804976207684E-12 |
| Normal-VS-KIRP CIMP |
1.156020E-01 |
| Normal-VS-Unclassified PRCC |
3.54510000000197E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.396000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.23899999998822E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
5.644600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.13069999999149E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
1.478440E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.575600E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.86106685617915E-12 |
| Normal-vs-N1 |
1.175780E-03 |
| Normal-vs-N2 |
4.32449999999696E-05 |
| N0-vs-N1 |
1.439930E-02 |
| N0-vs-N2 |
8.709000E-01 |
| N1-vs-N2 |
2.327000E-01 |
|
|
